Chemoinformaics analysis of Beta-Amyrin-Alpha-L-Rhamnosyl-O-Beta-D-Glucoside
| Molecular Weight | 735.012 | nRot | 5 |
| Heavy Atom Molecular Weight | 664.452 | nRig | 38 |
| Exact Molecular Weight | 734.497 | nRing | 7 |
| Solubility: LogS | -4.651 | nHRing | 2 |
| Solubility: LogP | 5.938 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 122 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 52 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 70 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 42 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 124.836 |
| nHD | 6 | BPOL | 77.1685 |
| QED | 0.171 |
| Synth | 5.65 |
| Natural Product Likeliness | 3.003 |
| NR-PPAR-gamma | 0.193 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.986 |
| Pgp-sub | 0.001 |
| HIA | 0.026 |
| CACO-2 | -5.265 |
| MDCK | 0.0000084 |
| BBB | 0.001 |
| PPB | 0.936473 |
| VDSS | 0.796 |
| FU | 0.0425502 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.336 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.833 |
| CYP2c9-inh | 0.056 |
| CYP2c9-sub | 0.04 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.167 |
| CYP3a4-sub | 0.152 |
| CL | 0.91 |
| T12 | 0.294 |
| hERG | 0.098 |
| Ames | 0.026 |
| ROA | 0.064 |
| SkinSen | 0.623 |
| Carcinogencity | 0.014 |
| EI | 0.018 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.49 |
| Antiviral | Yes |
| Prediction | 0.856921 |